Zhang, Junying, Che, Tiantian, Wang, Liting, Sun, Wei, Zhao, Jing, Chen, Jiajia, Liu, Yang, Pu, Qi, Zhang, Yu, Li, Jiani, Li, Zhangfu, Zhu, Zhaojing, Fu, Qihuan, Wang, Xiaoyang, and Yuan, Jiangbei
Acute kidney injury (AKI) stands as a prevalent and economically burdensome condition worldwide, yet its complex molecular mechanisms remain incompletely understood. To address this gap, our study employs a multifaceted approach, combining mass spectrometry and RNA sequencing technologies, to elucidate the intricate molecular landscape underlying nephrotoxin-induced AKI in mice by cisplatin- and LPS-induced. By examining the protein and RNA expression profiles, we aimed to uncover novel insights into the pathogenesis of AKI and identify potential diagnostic and therapeutic targets. Our results demonstrate significant down-regulation of Slc34a1 and Slc34a3, shedding light on their crucial roles in AKI pathology and highlighting their promise as actionable targets for diagnosis and treatment. This comprehensive analysis not only enhances our understanding of AKI pathophysiology but also offers valuable avenues for the development of targeted interventions to mitigate its clinical impact. Nephrotoxicity acute kidney injury (AKI) is a common clinical condition whose pathogenesis is the process by which some drugs, chemicals or other factors cause damage to the kidneys, resulting in impaired kidney function. Although it has been proved that different nephrotoxic substances can affect the kidney through different pathways, whether they have a commonality has not been registered. Here, we combined transcriptomics and proteomics to study the molecular mechanism of LPS and cisplatin-induced nephrotoxic acute kidney injury finding that the down-regulation of Slc34a1 and Slc34a3 may be a critical link in nephrotoxic acute kidney injury, which can be used as a marker for its early diagnosis. [Display omitted] • Protein and mRNA profiles of LPS and cisplatin-induced nephrotoxic acute kidney injury are presented. • Slc34a1 and Slc34a3 are downregulated in nephrotoxic acute kidney injury that can serve as a potential diagnostic target. • LPS and cisplatin-induced acute kidney injury model mice were used for this study. [ABSTRACT FROM AUTHOR]